Colonoscopy
Conditions
Keywords
BOWEL PREPARATION, PEG, Low-volume PEG Plus Ascorbic Acid
Brief summary
The purpose of this study is to compare the efficacy, acceptability and preparation-induced mucosal inflammation of PEG + ascorbic acid vs. PEG for colonoscopy.
Detailed description
This was a prospective randomized single-blinded clinical trial of ambulatory patients to assess the efficacy of bowel preparation and preparation-induced mucosal inflammation. Endoscopists who were blinded to the preparation taken, assessed both bowel cleansing by using the Ottawa bowel preparation assessment tool and preparation-induced mucosal inflammation. Acceptability was assessed by questionnaire.
Interventions
Sponsors
Inje University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients who want colonoscopy purposing screening among adults between the age of 20\ 65
Exclusion criteria
* Under the age of 20, older than 65, pregnant or lactating women, intestinal obstruction, structural intestinal disease, hypothyroidism, gastrointestinal motility, renal failure, congestive heart failure, liver failure, electrolyte abnormalities, who refused research informed consent, inflammatory bowel disease, the obvious symptoms of the disease in patients with lower gastrointestinal (bloody stools, diarrhea, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of colon cleansing between the two solutions using Ottawa scale | 3month |
Countries
South Korea
Outcome results
None listed